Health
Recipients testing positive in Israel sparks concern over Pfizer vaccine efficacy – Global Times
More than 12,400 in Israel were reportedly infected after accepting Pfizer’s COVID-19 vaccine, which led to doubts over the vaccine’s efficacy, despite the reported…
An illustration shows vials of a COVID-19 vaccine and syringes with the logos of US pharmaceutical company Pfizer and German partner BioNTech. Photo: AFP
More than 12,400 in Israel were reportedly infected after accepting Pfizer’s COVID-19 vaccine, which led to doubts over the vaccine’s efficacy, despite the reported 95 percent efficacy in Phase III clinical trials.
This can be a sign that the vaccine’s efficacy is not necessarily the same as data from experiments, which is affected by many elements…
Continue Reading
